CD1: From Molecules to Diseases

Overview

Journal F1000Res

Specialties Biomedical Engineering
Science

Date 2017 Nov 21

PMID 29152228

Citations 12

Authors

D Branch Moody

Sara Suliman

Affiliations

Soon will be listed here.

Abstract

The human cluster of differentiation (CD)1 system for antigen display is comprised of four types of antigen-presenting molecules, each with a distinct functional niche: CD1a, CD1b, CD1c, and CD1d. Whereas CD1 proteins were thought solely to influence T-cell responses through display of amphipathic lipids, recent studies emphasize the role of direct contacts between the T-cell receptor and CD1 itself. Moving from molecules to diseases, new research approaches emphasize human CD1-transgenic mouse models and the study of human polyclonal T cells or in disease states. Whereas the high genetic diversity of major histocompatibility complex (MHC)-encoded antigen-presenting molecules provides a major hurdle for designing antigens that activate T cells in all humans, the simple population genetics of the CD1 system offers the prospect of discovering or designing broadly acting immunomodulatory agents.

Citing Articles

BioDolphin as a comprehensive database of lipid-protein binding interactions.

Yang L, Ping K, Luo Y, McShan A Commun Chem. 2024; 7(1):288.

PMID: 39633021 PMC: 11618342. DOI: 10.1038/s42004-024-01384-z.

Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis.

Zhu R, Zhao Y, Yin H, Shu L, Ma Y, Tao Y Sci Rep. 2024; 14(1):29964.

PMID: 39622956 PMC: 11612211. DOI: 10.1038/s41598-024-81803-2.

Establishment of CD1b-restricted immunity to lipid antigens in the pulmonary response to infection.

Harris M, Gary H, Cooper S, Ackart D, DiLisio J, Basaraba R Infect Immun. 2024; 92(12):e0038024.

PMID: 39494875 PMC: 11629625. DOI: 10.1128/iai.00380-24.

Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer.

Ni L, Xu J, Li Q, Ge X, Wang F, Deng X Cancer Manag Res. 2024; 16:941-963.

PMID: 39099760 PMC: 11296367. DOI: 10.2147/CMAR.S474348.

CD1a and skin T cells: a pathway for therapeutic intervention.

Ye J, Chen Y, Ogg G Clin Exp Dermatol. 2024; 49(5):450-458.

PMID: 38173286 PMC: 11037390. DOI: 10.1093/ced/llad460.

References

Jackman R, Stenger S, Lee A, Moody D, Rogers R, Niazi K . The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity. 1998; 8(3):341-51. DOI: 10.1016/s1074-7613(00)80539-7. View

Dascher C, Hiromatsu K, Xiong X, Morehouse C, Watts G, Liu G . Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int Immunol. 2003; 15(8):915-25. DOI: 10.1093/intimm/dxg091. View

Birkinshaw R, Pellicci D, Cheng T, Keller A, Sandoval-Romero M, Gras S . αβ T cell antigen receptor recognition of CD1a presenting self lipid ligands. Nat Immunol. 2015; 16(3):258-66. PMC: 7103088. DOI: 10.1038/ni.3098. View

Bagchi S, He Y, Zhang H, Cao L, van Rhijn I, Moody D . CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017; 127(6):2339-2352. PMC: 5451229. DOI: 10.1172/JCI92217. View

Pellicci D, Clarke A, Patel O, Mallevaey T, Beddoe T, Le Nours J . Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol. 2011; 12(9):827-33. PMC: 5584936. DOI: 10.1038/ni.2076. View

de Jong A, Pena-Cruz V, Cheng T, Clark R, van Rhijn I, Moody D . CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. Nat Immunol. 2010; 11(12):1102-9. PMC: 3131223. DOI: 10.1038/ni.1956. View

Roura-Mir C, Wang L, Cheng T, Matsunaga I, Dascher C, Peng S . Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J Immunol. 2005; 175(3):1758-66. DOI: 10.4049/jimmunol.175.3.1758. View

Beckman E, Porcelli S, Morita C, Behar S, Furlong S, Brenner M . Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature. 1994; 372(6507):691-4. DOI: 10.1038/372691a0. View

Felio K, Nguyen H, Dascher C, Choi H, Li S, Zimmer M . CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. J Exp Med. 2009; 206(11):2497-509. PMC: 2768849. DOI: 10.1084/jem.20090898. View

10.

Roy S, Ly D, Castro C, Li N, Hawk A, Altman J . Molecular Analysis of Lipid-Reactive Vδ1 γδ T Cells Identified by CD1c Tetramers. J Immunol. 2016; 196(4):1933-42. PMC: 4744554. DOI: 10.4049/jimmunol.1502202. View

11.

Luoma A, Castro C, Mayassi T, Bembinster L, Bai L, Picard D . Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells. Immunity. 2013; 39(6):1032-42. PMC: 3875342. DOI: 10.1016/j.immuni.2013.11.001. View

12.

van Rhijn I, Godfrey D, Rossjohn J, Moody D . Lipid and small-molecule display by CD1 and MR1. Nat Rev Immunol. 2015; 15(10):643-54. PMC: 6944187. DOI: 10.1038/nri3889. View

13.

Sidobre S, Kronenberg M . CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells. J Immunol Methods. 2002; 268(1):107-21. DOI: 10.1016/s0022-1759(02)00204-1. View

14.

Mansour S, Tocheva A, Cave-Ayland C, Machelett M, Sander B, Lissin N . Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells. Proc Natl Acad Sci U S A. 2016; 113(9):E1266-75. PMC: 4780616. DOI: 10.1073/pnas.1519246113. View

15.

Zajonc D, Crispin M, Bowden T, Young D, Cheng T, Hu J . Molecular mechanism of lipopeptide presentation by CD1a. Immunity. 2005; 22(2):209-19. DOI: 10.1016/j.immuni.2004.12.009. View

16.

Reinink P, van Rhijn I . Mammalian CD1 and MR1 genes. Immunogenetics. 2016; 68(8):515-23. PMC: 5002277. DOI: 10.1007/s00251-016-0926-x. View

17.

Porcelli S, Morita C, Brenner M . CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature. 1992; 360(6404):593-7. DOI: 10.1038/360593a0. View

18.

De Libero G, Mori L . The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis. Front Immunol. 2014; 5:219. PMC: 4033098. DOI: 10.3389/fimmu.2014.00219. View

19.

Scriba T, Kaufmann S, Lambert P, Sanicas M, Martin C, Neyrolles O . Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines. J Infect Dis. 2016; 214(5):659-64. DOI: 10.1093/infdis/jiw228. View

20.

Moody D, Briken V, Cheng T, Roura-Mir C, Guy M, Geho D . Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol. 2002; 3(5):435-42. DOI: 10.1038/ni780. View